Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06926205 |
| Title | CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL (GELLC9RICHTER) |
| Acronym | GELLC9RICHTER |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GELLC (Grupo Español de Leucemia Linfocítica Crónica) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |